nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—restless legs syndrome—Clonidine—hypertension	0.222	1	CpDpCtD
Pramipexole—ADRA2B—hypertension	0.0711	0.261	CbGaD
Pramipexole—HTR2B—hypertension	0.0586	0.216	CbGaD
Pramipexole—HTR1B—hypertension	0.0352	0.129	CbGaD
Pramipexole—DRD3—hypertension	0.0341	0.125	CbGaD
Pramipexole—ADRA2A—hypertension	0.0311	0.114	CbGaD
Pramipexole—DRD2—hypertension	0.0236	0.0868	CbGaD
Pramipexole—HTR2A—hypertension	0.0182	0.0671	CbGaD
Pramipexole—DRD5—Fenoldopam—hypertension	0.0181	0.0607	CbGbCtD
Pramipexole—HTR1B—Pindolol—hypertension	0.0119	0.0402	CbGbCtD
Pramipexole—ADRA2C—Guanabenz—hypertension	0.0117	0.0392	CbGbCtD
Pramipexole—ADRA2B—Guanabenz—hypertension	0.0111	0.0372	CbGbCtD
Pramipexole—ADRA2B—Guanfacine—hypertension	0.0103	0.0346	CbGbCtD
Pramipexole—HTR1B—Penbutolol—hypertension	0.00974	0.0328	CbGbCtD
Pramipexole—SLC22A2—Metoprolol—hypertension	0.00949	0.0319	CbGbCtD
Pramipexole—DRD1—Fenoldopam—hypertension	0.00922	0.031	CbGbCtD
Pramipexole—ADRA2C—Fenoldopam—hypertension	0.00922	0.031	CbGbCtD
Pramipexole—SLC22A1—Acebutolol—hypertension	0.00887	0.0298	CbGbCtD
Pramipexole—HTR1A—Nebivolol—hypertension	0.0088	0.0296	CbGbCtD
Pramipexole—ADRA2B—Fenoldopam—hypertension	0.00875	0.0294	CbGbCtD
Pramipexole—SLC22A2—Reserpine—hypertension	0.00846	0.0284	CbGbCtD
Pramipexole—ADRA2A—Methyldopa—hypertension	0.00842	0.0283	CbGbCtD
Pramipexole—HTR1D—Prazosin—hypertension	0.00803	0.027	CbGbCtD
Pramipexole—ADRA2A—Guanabenz—hypertension	0.0077	0.0259	CbGbCtD
Pramipexole—HTR1A—Pindolol—hypertension	0.00748	0.0252	CbGbCtD
Pramipexole—SLC22A1—Reserpine—hypertension	0.00735	0.0247	CbGbCtD
Pramipexole—SLC22A2—Amiloride—hypertension	0.00719	0.0242	CbGbCtD
Pramipexole—ADRA2A—Guanfacine—hypertension	0.00716	0.0241	CbGbCtD
Pramipexole—ADRA2B—Prazosin—hypertension	0.00663	0.0223	CbGbCtD
Pramipexole—SLC22A1—Amiloride—hypertension	0.00625	0.021	CbGbCtD
Pramipexole—HTR1B—Propranolol—hypertension	0.00611	0.0206	CbGbCtD
Pramipexole—SLC22A2—Prazosin—hypertension	0.00611	0.0206	CbGbCtD
Pramipexole—HTR1A—Penbutolol—hypertension	0.0061	0.0205	CbGbCtD
Pramipexole—ADRA2A—Fenoldopam—hypertension	0.00608	0.0205	CbGbCtD
Pramipexole—ADRA2C—Carvedilol—hypertension	0.00603	0.0203	CbGbCtD
Pramipexole—ADRA2B—Carvedilol—hypertension	0.00572	0.0192	CbGbCtD
Pramipexole—ADRA2A—Doxazosin—hypertension	0.00561	0.0189	CbGbCtD
Pramipexole—DRD2—Fenoldopam—hypertension	0.0056	0.0189	CbGbCtD
Pramipexole—SLC22A1—Prazosin—hypertension	0.00531	0.0179	CbGbCtD
Pramipexole—ADRA2C—Clonidine—hypertension	0.0053	0.0178	CbGbCtD
Pramipexole—ADRA2B—Clonidine—hypertension	0.00502	0.0169	CbGbCtD
Pramipexole—SLC22A2—Propranolol—hypertension	0.00486	0.0163	CbGbCtD
Pramipexole—HTR1A—Prazosin—hypertension	0.00482	0.0162	CbGbCtD
Pramipexole—ADRA2A—Prazosin—hypertension	0.00461	0.0155	CbGbCtD
Pramipexole—SLC22A1—Clonidine—hypertension	0.00403	0.0135	CbGbCtD
Pramipexole—ADRA2A—Carvedilol—hypertension	0.00398	0.0134	CbGbCtD
Pramipexole—HTR1A—Propranolol—hypertension	0.00383	0.0129	CbGbCtD
Pramipexole—ADRA2A—Clonidine—hypertension	0.00349	0.0118	CbGbCtD
Pramipexole—SLC22A1—Verapamil—hypertension	0.0029	0.00974	CbGbCtD
Pramipexole—SLC22A2—nephron—hypertension	0.00136	0.0677	CbGeAlD
Pramipexole—HTR2A—arteriole—hypertension	0.00109	0.0541	CbGeAlD
Pramipexole—HTR2A—locus ceruleus—hypertension	0.000878	0.0436	CbGeAlD
Pramipexole—HTR2A—pulmonary artery—hypertension	0.000714	0.0354	CbGeAlD
Pramipexole—HTR2A—sympathetic nervous system—hypertension	0.000694	0.0345	CbGeAlD
Pramipexole—HTR2A—vagus nerve—hypertension	0.000672	0.0334	CbGeAlD
Pramipexole—HTR2A—vein—hypertension	0.00065	0.0323	CbGeAlD
Pramipexole—HTR1B—artery—hypertension	0.00055	0.0273	CbGeAlD
Pramipexole—HTR1D—artery—hypertension	0.000533	0.0264	CbGeAlD
Pramipexole—DRD4—heart—hypertension	0.000497	0.0247	CbGeAlD
Pramipexole—HTR2A—autonomic nervous system—hypertension	0.000467	0.0232	CbGeAlD
Pramipexole—HTR2A—hindlimb—hypertension	0.000432	0.0214	CbGeAlD
Pramipexole—HTR1B—blood vessel—hypertension	0.000429	0.0213	CbGeAlD
Pramipexole—HTR1D—blood vessel—hypertension	0.000415	0.0206	CbGeAlD
Pramipexole—HTR2A—urine—hypertension	0.00038	0.0189	CbGeAlD
Pramipexole—SLC22A2—nephron tubule—hypertension	0.000294	0.0146	CbGeAlD
Pramipexole—DRD1—brainstem—hypertension	0.000289	0.0144	CbGeAlD
Pramipexole—HTR2A—artery—hypertension	0.000265	0.0131	CbGeAlD
Pramipexole—SLC22A2—kidney—hypertension	0.000259	0.0128	CbGeAlD
Pramipexole—SLC22A2—cortex of kidney—hypertension	0.000252	0.0125	CbGeAlD
Pramipexole—HTR1B—brainstem—hypertension	0.000234	0.0116	CbGeAlD
Pramipexole—HTR1D—brainstem—hypertension	0.000227	0.0113	CbGeAlD
Pramipexole—HTR2C—brainstem—hypertension	0.000225	0.0112	CbGeAlD
Pramipexole—HTR2A—endothelium—hypertension	0.000223	0.0111	CbGeAlD
Pramipexole—ADRA2C—cardiac ventricle—hypertension	0.000219	0.0109	CbGeAlD
Pramipexole—DRD5—endocrine gland—hypertension	0.000212	0.0105	CbGeAlD
Pramipexole—HTR2A—blood vessel—hypertension	0.000206	0.0102	CbGeAlD
Pramipexole—ADRA2C—myocardium—hypertension	0.000206	0.0102	CbGeAlD
Pramipexole—DRD3—central nervous system—hypertension	0.000204	0.0101	CbGeAlD
Pramipexole—HTR1B—cardiovascular system—hypertension	0.000191	0.00949	CbGeAlD
Pramipexole—DRD5—central nervous system—hypertension	0.000191	0.00948	CbGeAlD
Pramipexole—HTR1A—brainstem—hypertension	0.000189	0.00939	CbGeAlD
Pramipexole—HTR2B—adrenal cortex—hypertension	0.000189	0.00937	CbGeAlD
Pramipexole—HTR1D—cardiovascular system—hypertension	0.000185	0.00919	CbGeAlD
Pramipexole—SLC22A1—kidney—hypertension	0.000183	0.00908	CbGeAlD
Pramipexole—HTR2B—heart—hypertension	0.000182	0.00906	CbGeAlD
Pramipexole—HTR1D—kidney—hypertension	0.000181	0.00899	CbGeAlD
Pramipexole—HTR2B—smooth muscle tissue—hypertension	0.000181	0.00899	CbGeAlD
Pramipexole—HTR2B—decidua—hypertension	0.000177	0.00881	CbGeAlD
Pramipexole—HTR2B—cardiovascular system—hypertension	0.000172	0.00855	CbGeAlD
Pramipexole—DRD2—brainstem—hypertension	0.000171	0.00848	CbGeAlD
Pramipexole—HTR2B—cortex of kidney—hypertension	0.000164	0.00815	CbGeAlD
Pramipexole—HTR2C—medulla oblongata—hypertension	0.000157	0.00778	CbGeAlD
Pramipexole—HTR1A—cardiovascular system—hypertension	0.000154	0.00766	CbGeAlD
Pramipexole—ADRA2C—nephron tubule—hypertension	0.000151	0.00749	CbGeAlD
Pramipexole—ADRA2C—adrenal cortex—hypertension	0.000149	0.00737	CbGeAlD
Pramipexole—DRD1—central nervous system—hypertension	0.000146	0.00724	CbGeAlD
Pramipexole—ADRA2C—heart—hypertension	0.000144	0.00713	CbGeAlD
Pramipexole—ADRA2C—decidua—hypertension	0.00014	0.00694	CbGeAlD
Pramipexole—HTR2B—adrenal gland—hypertension	0.000136	0.00676	CbGeAlD
Pramipexole—ADRA2C—kidney—hypertension	0.000133	0.00658	CbGeAlD
Pramipexole—HTR1B—endocrine gland—hypertension	0.000131	0.00651	CbGeAlD
Pramipexole—ADRA2C—cortex of kidney—hypertension	0.000129	0.00641	CbGeAlD
Pramipexole—SLC22A1—endocrine gland—hypertension	0.000128	0.00636	CbGeAlD
Pramipexole—ADRA2C—cardiac atrium—hypertension	0.000123	0.0061	CbGeAlD
Pramipexole—HTR1A—adrenal gland—hypertension	0.000122	0.00606	CbGeAlD
Pramipexole—HTR1B—central nervous system—hypertension	0.000118	0.00587	CbGeAlD
Pramipexole—ADRA2C—medulla oblongata—hypertension	0.000116	0.00575	CbGeAlD
Pramipexole—SLC22A1—central nervous system—hypertension	0.000115	0.00573	CbGeAlD
Pramipexole—ADRA2A—heart—hypertension	0.000115	0.00569	CbGeAlD
Pramipexole—HTR1D—central nervous system—hypertension	0.000114	0.00568	CbGeAlD
Pramipexole—HTR2C—central nervous system—hypertension	0.000113	0.00563	CbGeAlD
Pramipexole—HTR2A—brainstem—hypertension	0.000113	0.00559	CbGeAlD
Pramipexole—ADRA2A—decidua—hypertension	0.000111	0.00553	CbGeAlD
Pramipexole—ADRA2C—adrenal gland—hypertension	0.000107	0.00532	CbGeAlD
Pramipexole—HTR2B—central nervous system—hypertension	0.000106	0.00528	CbGeAlD
Pramipexole—HTR1A—endocrine gland—hypertension	0.000106	0.00525	CbGeAlD
Pramipexole—ADRA2A—cortex of kidney—hypertension	0.000103	0.00512	CbGeAlD
Pramipexole—ADRA2A—cardiac atrium—hypertension	9.8e-05	0.00487	CbGeAlD
Pramipexole—HTR2A—heart—hypertension	9.74e-05	0.00484	CbGeAlD
Pramipexole—HTR2A—smooth muscle tissue—hypertension	9.67e-05	0.0048	CbGeAlD
Pramipexole—DRD2—endocrine gland—hypertension	9.56e-05	0.00475	CbGeAlD
Pramipexole—HTR1A—central nervous system—hypertension	9.54e-05	0.00474	CbGeAlD
Pramipexole—ADRA2A—medulla oblongata—hypertension	9.24e-05	0.00459	CbGeAlD
Pramipexole—HTR2A—cardiovascular system—hypertension	9.19e-05	0.00457	CbGeAlD
Pramipexole—HTR2A—kidney—hypertension	9e-05	0.00447	CbGeAlD
Pramipexole—DRD2—central nervous system—hypertension	8.62e-05	0.00428	CbGeAlD
Pramipexole—ADRA2A—adrenal gland—hypertension	8.55e-05	0.00425	CbGeAlD
Pramipexole—ADRA2C—central nervous system—hypertension	8.38e-05	0.00416	CbGeAlD
Pramipexole—HTR2A—medulla oblongata—hypertension	7.86e-05	0.0039	CbGeAlD
Pramipexole—ADRA2A—endocrine gland—hypertension	7.42e-05	0.00368	CbGeAlD
Pramipexole—HTR2A—adrenal gland—hypertension	7.27e-05	0.00361	CbGeAlD
Pramipexole—ADRA2A—central nervous system—hypertension	6.68e-05	0.00332	CbGeAlD
Pramipexole—HTR2A—endocrine gland—hypertension	6.31e-05	0.00313	CbGeAlD
Pramipexole—HTR2A—central nervous system—hypertension	5.68e-05	0.00282	CbGeAlD
Pramipexole—Thrombocytopenia—Ramipril—hypertension	5.9e-06	5.01e-05	CcSEcCtD
Pramipexole—Oedema—Timolol—hypertension	5.89e-06	5e-05	CcSEcCtD
Pramipexole—Loss of consciousness—Lisinopril—hypertension	5.88e-06	5e-05	CcSEcCtD
Pramipexole—Rash—Verapamil—hypertension	5.88e-06	5e-05	CcSEcCtD
Pramipexole—Urticaria—Hydrochlorothiazide—hypertension	5.88e-06	5e-05	CcSEcCtD
Pramipexole—Tachycardia—Ramipril—hypertension	5.88e-06	4.99e-05	CcSEcCtD
Pramipexole—Dermatitis—Verapamil—hypertension	5.88e-06	4.99e-05	CcSEcCtD
Pramipexole—Headache—Nifedipine—hypertension	5.87e-06	4.99e-05	CcSEcCtD
Pramipexole—Pruritus—Clonidine—hypertension	5.86e-06	4.98e-05	CcSEcCtD
Pramipexole—Body temperature increased—Hydrochlorothiazide—hypertension	5.85e-06	4.97e-05	CcSEcCtD
Pramipexole—Abdominal pain—Hydrochlorothiazide—hypertension	5.85e-06	4.97e-05	CcSEcCtD
Pramipexole—Skin disorder—Ramipril—hypertension	5.85e-06	4.97e-05	CcSEcCtD
Pramipexole—Infection—Timolol—hypertension	5.85e-06	4.97e-05	CcSEcCtD
Pramipexole—Headache—Verapamil—hypertension	5.84e-06	4.97e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Telmisartan—hypertension	5.84e-06	4.97e-05	CcSEcCtD
Pramipexole—Cough—Lisinopril—hypertension	5.84e-06	4.96e-05	CcSEcCtD
Pramipexole—Nausea—Diltiazem—hypertension	5.83e-06	4.95e-05	CcSEcCtD
Pramipexole—Nausea—Indapamide—hypertension	5.83e-06	4.95e-05	CcSEcCtD
Pramipexole—Hyperhidrosis—Ramipril—hypertension	5.82e-06	4.95e-05	CcSEcCtD
Pramipexole—Asthenia—Trandolapril—hypertension	5.79e-06	4.92e-05	CcSEcCtD
Pramipexole—Shock—Timolol—hypertension	5.79e-06	4.92e-05	CcSEcCtD
Pramipexole—Feeling abnormal—Losartan—hypertension	5.79e-06	4.92e-05	CcSEcCtD
Pramipexole—Urticaria—Furosemide—hypertension	5.78e-06	4.91e-05	CcSEcCtD
Pramipexole—Nervous system disorder—Timolol—hypertension	5.77e-06	4.91e-05	CcSEcCtD
Pramipexole—Nausea—Carvedilol—hypertension	5.77e-06	4.91e-05	CcSEcCtD
Pramipexole—Asthenia—Enalapril—hypertension	5.77e-06	4.9e-05	CcSEcCtD
Pramipexole—Body temperature increased—Furosemide—hypertension	5.76e-06	4.89e-05	CcSEcCtD
Pramipexole—Abdominal pain—Furosemide—hypertension	5.76e-06	4.89e-05	CcSEcCtD
Pramipexole—Gastrointestinal pain—Losartan—hypertension	5.74e-06	4.88e-05	CcSEcCtD
Pramipexole—Dizziness—Valsartan—hypertension	5.74e-06	4.88e-05	CcSEcCtD
Pramipexole—Anorexia—Ramipril—hypertension	5.74e-06	4.88e-05	CcSEcCtD
Pramipexole—Urticaria—Betaxolol—hypertension	5.73e-06	4.87e-05	CcSEcCtD
Pramipexole—Skin disorder—Timolol—hypertension	5.72e-06	4.86e-05	CcSEcCtD
Pramipexole—Dizziness—Olmesartan—hypertension	5.72e-06	4.86e-05	CcSEcCtD
Pramipexole—Pruritus—Trandolapril—hypertension	5.71e-06	4.85e-05	CcSEcCtD
Pramipexole—Nausea—Doxazosin—hypertension	5.71e-06	4.85e-05	CcSEcCtD
Pramipexole—Arthralgia—Lisinopril—hypertension	5.7e-06	4.84e-05	CcSEcCtD
Pramipexole—Chest pain—Lisinopril—hypertension	5.7e-06	4.84e-05	CcSEcCtD
Pramipexole—Myalgia—Lisinopril—hypertension	5.7e-06	4.84e-05	CcSEcCtD
Pramipexole—Body temperature increased—Betaxolol—hypertension	5.7e-06	4.84e-05	CcSEcCtD
Pramipexole—Hyperhidrosis—Timolol—hypertension	5.69e-06	4.84e-05	CcSEcCtD
Pramipexole—Asthenia—Telmisartan—hypertension	5.69e-06	4.84e-05	CcSEcCtD
Pramipexole—Pruritus—Enalapril—hypertension	5.69e-06	4.83e-05	CcSEcCtD
Pramipexole—Anxiety—Lisinopril—hypertension	5.68e-06	4.82e-05	CcSEcCtD
Pramipexole—Diarrhoea—Clonidine—hypertension	5.66e-06	4.81e-05	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	5.66e-06	4.81e-05	CcSEcCtD
Pramipexole—Nausea—Fosinopril—hypertension	5.64e-06	4.79e-05	CcSEcCtD
Pramipexole—Discomfort—Lisinopril—hypertension	5.63e-06	4.78e-05	CcSEcCtD
Pramipexole—Hypotension—Ramipril—hypertension	5.63e-06	4.78e-05	CcSEcCtD
Pramipexole—Anorexia—Timolol—hypertension	5.61e-06	4.77e-05	CcSEcCtD
Pramipexole—Pruritus—Telmisartan—hypertension	5.61e-06	4.77e-05	CcSEcCtD
Pramipexole—Nausea—Eplerenone—hypertension	5.61e-06	4.76e-05	CcSEcCtD
Pramipexole—Urticaria—Losartan—hypertension	5.58e-06	4.74e-05	CcSEcCtD
Pramipexole—Dry mouth—Lisinopril—hypertension	5.57e-06	4.74e-05	CcSEcCtD
Pramipexole—Nausea—Nifedipine—hypertension	5.57e-06	4.73e-05	CcSEcCtD
Pramipexole—Abdominal pain—Losartan—hypertension	5.55e-06	4.72e-05	CcSEcCtD
Pramipexole—Body temperature increased—Losartan—hypertension	5.55e-06	4.72e-05	CcSEcCtD
Pramipexole—Nausea—Verapamil—hypertension	5.54e-06	4.71e-05	CcSEcCtD
Pramipexole—Asthenia—Captopril—hypertension	5.53e-06	4.7e-05	CcSEcCtD
Pramipexole—Diarrhoea—Trandolapril—hypertension	5.52e-06	4.69e-05	CcSEcCtD
Pramipexole—Vomiting—Valsartan—hypertension	5.52e-06	4.69e-05	CcSEcCtD
Pramipexole—Confusional state—Lisinopril—hypertension	5.51e-06	4.68e-05	CcSEcCtD
Pramipexole—Diarrhoea—Enalapril—hypertension	5.5e-06	4.68e-05	CcSEcCtD
Pramipexole—Hypotension—Timolol—hypertension	5.5e-06	4.68e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Irbesartan—hypertension	5.5e-06	4.67e-05	CcSEcCtD
Pramipexole—Vomiting—Olmesartan—hypertension	5.5e-06	4.67e-05	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Ramipril—hypertension	5.49e-06	4.66e-05	CcSEcCtD
Pramipexole—Rash—Valsartan—hypertension	5.48e-06	4.65e-05	CcSEcCtD
Pramipexole—Dizziness—Clonidine—hypertension	5.47e-06	4.65e-05	CcSEcCtD
Pramipexole—Dermatitis—Valsartan—hypertension	5.47e-06	4.65e-05	CcSEcCtD
Pramipexole—Oedema—Lisinopril—hypertension	5.46e-06	4.64e-05	CcSEcCtD
Pramipexole—Pruritus—Captopril—hypertension	5.46e-06	4.64e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Hydrochlorothiazide—hypertension	5.45e-06	4.63e-05	CcSEcCtD
Pramipexole—Rash—Olmesartan—hypertension	5.45e-06	4.63e-05	CcSEcCtD
Pramipexole—Insomnia—Ramipril—hypertension	5.45e-06	4.63e-05	CcSEcCtD
Pramipexole—Dermatitis—Olmesartan—hypertension	5.45e-06	4.63e-05	CcSEcCtD
Pramipexole—Headache—Valsartan—hypertension	5.44e-06	4.62e-05	CcSEcCtD
Pramipexole—Diarrhoea—Telmisartan—hypertension	5.43e-06	4.61e-05	CcSEcCtD
Pramipexole—Infection—Lisinopril—hypertension	5.43e-06	4.61e-05	CcSEcCtD
Pramipexole—Headache—Olmesartan—hypertension	5.42e-06	4.6e-05	CcSEcCtD
Pramipexole—Paraesthesia—Ramipril—hypertension	5.41e-06	4.6e-05	CcSEcCtD
Pramipexole—Shock—Lisinopril—hypertension	5.37e-06	4.57e-05	CcSEcCtD
Pramipexole—Asthenia—Perindopril—hypertension	5.37e-06	4.57e-05	CcSEcCtD
Pramipexole—Dyspnoea—Ramipril—hypertension	5.37e-06	4.56e-05	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Timolol—hypertension	5.36e-06	4.56e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Furosemide—hypertension	5.36e-06	4.56e-05	CcSEcCtD
Pramipexole—Asthenia—Irbesartan—hypertension	5.36e-06	4.55e-05	CcSEcCtD
Pramipexole—Somnolence—Ramipril—hypertension	5.35e-06	4.55e-05	CcSEcCtD
Pramipexole—Thrombocytopenia—Lisinopril—hypertension	5.35e-06	4.54e-05	CcSEcCtD
Pramipexole—Dizziness—Trandolapril—hypertension	5.34e-06	4.54e-05	CcSEcCtD
Pramipexole—Tachycardia—Lisinopril—hypertension	5.33e-06	4.53e-05	CcSEcCtD
Pramipexole—Insomnia—Timolol—hypertension	5.33e-06	4.53e-05	CcSEcCtD
Pramipexole—Dizziness—Enalapril—hypertension	5.32e-06	4.52e-05	CcSEcCtD
Pramipexole—Asthenia—Hydrochlorothiazide—hypertension	5.31e-06	4.51e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Betaxolol—hypertension	5.31e-06	4.51e-05	CcSEcCtD
Pramipexole—Skin disorder—Lisinopril—hypertension	5.31e-06	4.51e-05	CcSEcCtD
Pramipexole—Dyspepsia—Ramipril—hypertension	5.3e-06	4.5e-05	CcSEcCtD
Pramipexole—Pruritus—Perindopril—hypertension	5.3e-06	4.5e-05	CcSEcCtD
Pramipexole—Paraesthesia—Timolol—hypertension	5.29e-06	4.49e-05	CcSEcCtD
Pramipexole—Pruritus—Irbesartan—hypertension	5.28e-06	4.49e-05	CcSEcCtD
Pramipexole—Hyperhidrosis—Lisinopril—hypertension	5.28e-06	4.49e-05	CcSEcCtD
Pramipexole—Diarrhoea—Captopril—hypertension	5.28e-06	4.48e-05	CcSEcCtD
Pramipexole—Vomiting—Clonidine—hypertension	5.26e-06	4.47e-05	CcSEcCtD
Pramipexole—Dyspnoea—Timolol—hypertension	5.25e-06	4.46e-05	CcSEcCtD
Pramipexole—Dizziness—Telmisartan—hypertension	5.25e-06	4.46e-05	CcSEcCtD
Pramipexole—Pruritus—Hydrochlorothiazide—hypertension	5.24e-06	4.45e-05	CcSEcCtD
Pramipexole—Decreased appetite—Ramipril—hypertension	5.24e-06	4.45e-05	CcSEcCtD
Pramipexole—Somnolence—Timolol—hypertension	5.23e-06	4.45e-05	CcSEcCtD
Pramipexole—Asthenia—Furosemide—hypertension	5.22e-06	4.44e-05	CcSEcCtD
Pramipexole—Rash—Clonidine—hypertension	5.22e-06	4.44e-05	CcSEcCtD
Pramipexole—Dermatitis—Clonidine—hypertension	5.22e-06	4.43e-05	CcSEcCtD
Pramipexole—Anorexia—Lisinopril—hypertension	5.21e-06	4.42e-05	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Ramipril—hypertension	5.2e-06	4.42e-05	CcSEcCtD
Pramipexole—Fatigue—Ramipril—hypertension	5.19e-06	4.41e-05	CcSEcCtD
Pramipexole—Headache—Clonidine—hypertension	5.19e-06	4.41e-05	CcSEcCtD
Pramipexole—Dyspepsia—Timolol—hypertension	5.18e-06	4.4e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Losartan—hypertension	5.18e-06	4.4e-05	CcSEcCtD
Pramipexole—Asthenia—Betaxolol—hypertension	5.17e-06	4.39e-05	CcSEcCtD
Pramipexole—Nausea—Valsartan—hypertension	5.16e-06	4.38e-05	CcSEcCtD
Pramipexole—Pruritus—Furosemide—hypertension	5.15e-06	4.38e-05	CcSEcCtD
Pramipexole—Constipation—Ramipril—hypertension	5.15e-06	4.38e-05	CcSEcCtD
Pramipexole—Nausea—Olmesartan—hypertension	5.13e-06	4.36e-05	CcSEcCtD
Pramipexole—Vomiting—Trandolapril—hypertension	5.13e-06	4.36e-05	CcSEcCtD
Pramipexole—Diarrhoea—Perindopril—hypertension	5.12e-06	4.35e-05	CcSEcCtD
Pramipexole—Decreased appetite—Timolol—hypertension	5.12e-06	4.35e-05	CcSEcCtD
Pramipexole—Vomiting—Enalapril—hypertension	5.11e-06	4.34e-05	CcSEcCtD
Pramipexole—Diarrhoea—Irbesartan—hypertension	5.11e-06	4.34e-05	CcSEcCtD
Pramipexole—Hypotension—Lisinopril—hypertension	5.1e-06	4.34e-05	CcSEcCtD
Pramipexole—Dizziness—Captopril—hypertension	5.1e-06	4.33e-05	CcSEcCtD
Pramipexole—Pruritus—Betaxolol—hypertension	5.1e-06	4.33e-05	CcSEcCtD
Pramipexole—Rash—Trandolapril—hypertension	5.09e-06	4.33e-05	CcSEcCtD
Pramipexole—Dermatitis—Trandolapril—hypertension	5.09e-06	4.32e-05	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Timolol—hypertension	5.08e-06	4.32e-05	CcSEcCtD
Pramipexole—Fatigue—Timolol—hypertension	5.08e-06	4.31e-05	CcSEcCtD
Pramipexole—Rash—Enalapril—hypertension	5.07e-06	4.31e-05	CcSEcCtD
Pramipexole—Dermatitis—Enalapril—hypertension	5.07e-06	4.3e-05	CcSEcCtD
Pramipexole—Diarrhoea—Hydrochlorothiazide—hypertension	5.07e-06	4.3e-05	CcSEcCtD
Pramipexole—Headache—Trandolapril—hypertension	5.06e-06	4.3e-05	CcSEcCtD
Pramipexole—Vomiting—Telmisartan—hypertension	5.04e-06	4.29e-05	CcSEcCtD
Pramipexole—Asthenia—Losartan—hypertension	5.04e-06	4.28e-05	CcSEcCtD
Pramipexole—Headache—Enalapril—hypertension	5.04e-06	4.28e-05	CcSEcCtD
Pramipexole—Pain—Timolol—hypertension	5.04e-06	4.28e-05	CcSEcCtD
Pramipexole—Rash—Telmisartan—hypertension	5e-06	4.25e-05	CcSEcCtD
Pramipexole—Dermatitis—Telmisartan—hypertension	5e-06	4.25e-05	CcSEcCtD
Pramipexole—Diarrhoea—Furosemide—hypertension	4.98e-06	4.23e-05	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Lisinopril—hypertension	4.98e-06	4.23e-05	CcSEcCtD
Pramipexole—Pruritus—Losartan—hypertension	4.97e-06	4.22e-05	CcSEcCtD
Pramipexole—Headache—Telmisartan—hypertension	4.97e-06	4.22e-05	CcSEcCtD
Pramipexole—Feeling abnormal—Ramipril—hypertension	4.96e-06	4.22e-05	CcSEcCtD
Pramipexole—Dizziness—Perindopril—hypertension	4.95e-06	4.21e-05	CcSEcCtD
Pramipexole—Insomnia—Lisinopril—hypertension	4.94e-06	4.2e-05	CcSEcCtD
Pramipexole—Dizziness—Irbesartan—hypertension	4.94e-06	4.19e-05	CcSEcCtD
Pramipexole—Diarrhoea—Betaxolol—hypertension	4.93e-06	4.19e-05	CcSEcCtD
Pramipexole—Gastrointestinal pain—Ramipril—hypertension	4.93e-06	4.18e-05	CcSEcCtD
Pramipexole—Nausea—Clonidine—hypertension	4.92e-06	4.18e-05	CcSEcCtD
Pramipexole—Paraesthesia—Lisinopril—hypertension	4.91e-06	4.17e-05	CcSEcCtD
Pramipexole—Vomiting—Captopril—hypertension	4.9e-06	4.17e-05	CcSEcCtD
Pramipexole—Dizziness—Hydrochlorothiazide—hypertension	4.9e-06	4.16e-05	CcSEcCtD
Pramipexole—Dyspnoea—Lisinopril—hypertension	4.87e-06	4.14e-05	CcSEcCtD
Pramipexole—Rash—Captopril—hypertension	4.86e-06	4.13e-05	CcSEcCtD
Pramipexole—Dermatitis—Captopril—hypertension	4.86e-06	4.13e-05	CcSEcCtD
Pramipexole—Somnolence—Lisinopril—hypertension	4.86e-06	4.13e-05	CcSEcCtD
Pramipexole—Feeling abnormal—Timolol—hypertension	4.85e-06	4.12e-05	CcSEcCtD
Pramipexole—Headache—Captopril—hypertension	4.83e-06	4.11e-05	CcSEcCtD
Pramipexole—Gastrointestinal pain—Timolol—hypertension	4.82e-06	4.09e-05	CcSEcCtD
Pramipexole—Dizziness—Furosemide—hypertension	4.81e-06	4.09e-05	CcSEcCtD
Pramipexole—Dyspepsia—Lisinopril—hypertension	4.81e-06	4.09e-05	CcSEcCtD
Pramipexole—Diarrhoea—Losartan—hypertension	4.81e-06	4.08e-05	CcSEcCtD
Pramipexole—Nausea—Trandolapril—hypertension	4.8e-06	4.08e-05	CcSEcCtD
Pramipexole—Urticaria—Ramipril—hypertension	4.79e-06	4.07e-05	CcSEcCtD
Pramipexole—Nausea—Enalapril—hypertension	4.78e-06	4.06e-05	CcSEcCtD
Pramipexole—Dizziness—Betaxolol—hypertension	4.77e-06	4.05e-05	CcSEcCtD
Pramipexole—Vomiting—Perindopril—hypertension	4.76e-06	4.05e-05	CcSEcCtD
Pramipexole—Abdominal pain—Ramipril—hypertension	4.76e-06	4.05e-05	CcSEcCtD
Pramipexole—Body temperature increased—Ramipril—hypertension	4.76e-06	4.05e-05	CcSEcCtD
Pramipexole—Decreased appetite—Lisinopril—hypertension	4.75e-06	4.03e-05	CcSEcCtD
Pramipexole—Vomiting—Irbesartan—hypertension	4.75e-06	4.03e-05	CcSEcCtD
Pramipexole—Rash—Perindopril—hypertension	4.72e-06	4.01e-05	CcSEcCtD
Pramipexole—Dermatitis—Perindopril—hypertension	4.72e-06	4.01e-05	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Lisinopril—hypertension	4.72e-06	4.01e-05	CcSEcCtD
Pramipexole—Nausea—Telmisartan—hypertension	4.71e-06	4e-05	CcSEcCtD
Pramipexole—Fatigue—Lisinopril—hypertension	4.71e-06	4e-05	CcSEcCtD
Pramipexole—Vomiting—Hydrochlorothiazide—hypertension	4.71e-06	4e-05	CcSEcCtD
Pramipexole—Rash—Irbesartan—hypertension	4.71e-06	4e-05	CcSEcCtD
Pramipexole—Dermatitis—Irbesartan—hypertension	4.7e-06	4e-05	CcSEcCtD
Pramipexole—Headache—Perindopril—hypertension	4.69e-06	3.99e-05	CcSEcCtD
Pramipexole—Urticaria—Timolol—hypertension	4.68e-06	3.97e-05	CcSEcCtD
Pramipexole—Headache—Irbesartan—hypertension	4.68e-06	3.97e-05	CcSEcCtD
Pramipexole—Pain—Lisinopril—hypertension	4.67e-06	3.97e-05	CcSEcCtD
Pramipexole—Constipation—Lisinopril—hypertension	4.67e-06	3.97e-05	CcSEcCtD
Pramipexole—Rash—Hydrochlorothiazide—hypertension	4.67e-06	3.97e-05	CcSEcCtD
Pramipexole—Dermatitis—Hydrochlorothiazide—hypertension	4.66e-06	3.96e-05	CcSEcCtD
Pramipexole—Body temperature increased—Timolol—hypertension	4.65e-06	3.96e-05	CcSEcCtD
Pramipexole—Abdominal pain—Timolol—hypertension	4.65e-06	3.96e-05	CcSEcCtD
Pramipexole—Dizziness—Losartan—hypertension	4.65e-06	3.95e-05	CcSEcCtD
Pramipexole—Headache—Hydrochlorothiazide—hypertension	4.64e-06	3.94e-05	CcSEcCtD
Pramipexole—Vomiting—Furosemide—hypertension	4.63e-06	3.93e-05	CcSEcCtD
Pramipexole—Rash—Furosemide—hypertension	4.59e-06	3.9e-05	CcSEcCtD
Pramipexole—Dermatitis—Furosemide—hypertension	4.59e-06	3.9e-05	CcSEcCtD
Pramipexole—Vomiting—Betaxolol—hypertension	4.58e-06	3.89e-05	CcSEcCtD
Pramipexole—Nausea—Captopril—hypertension	4.58e-06	3.89e-05	CcSEcCtD
Pramipexole—Headache—Furosemide—hypertension	4.56e-06	3.88e-05	CcSEcCtD
Pramipexole—Rash—Betaxolol—hypertension	4.54e-06	3.86e-05	CcSEcCtD
Pramipexole—Dermatitis—Betaxolol—hypertension	4.54e-06	3.86e-05	CcSEcCtD
Pramipexole—Headache—Betaxolol—hypertension	4.52e-06	3.84e-05	CcSEcCtD
Pramipexole—Feeling abnormal—Lisinopril—hypertension	4.5e-06	3.82e-05	CcSEcCtD
Pramipexole—Gastrointestinal pain—Lisinopril—hypertension	4.47e-06	3.8e-05	CcSEcCtD
Pramipexole—Vomiting—Losartan—hypertension	4.47e-06	3.79e-05	CcSEcCtD
Pramipexole—Nausea—Perindopril—hypertension	4.45e-06	3.78e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Ramipril—hypertension	4.44e-06	3.77e-05	CcSEcCtD
Pramipexole—Nausea—Irbesartan—hypertension	4.43e-06	3.77e-05	CcSEcCtD
Pramipexole—Rash—Losartan—hypertension	4.43e-06	3.76e-05	CcSEcCtD
Pramipexole—Dermatitis—Losartan—hypertension	4.43e-06	3.76e-05	CcSEcCtD
Pramipexole—Headache—Losartan—hypertension	4.4e-06	3.74e-05	CcSEcCtD
Pramipexole—Nausea—Hydrochlorothiazide—hypertension	4.4e-06	3.74e-05	CcSEcCtD
Pramipexole—Urticaria—Lisinopril—hypertension	4.34e-06	3.69e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Timolol—hypertension	4.34e-06	3.69e-05	CcSEcCtD
Pramipexole—Nausea—Furosemide—hypertension	4.32e-06	3.67e-05	CcSEcCtD
Pramipexole—Asthenia—Ramipril—hypertension	4.32e-06	3.67e-05	CcSEcCtD
Pramipexole—Abdominal pain—Lisinopril—hypertension	4.32e-06	3.67e-05	CcSEcCtD
Pramipexole—Body temperature increased—Lisinopril—hypertension	4.32e-06	3.67e-05	CcSEcCtD
Pramipexole—Nausea—Betaxolol—hypertension	4.28e-06	3.64e-05	CcSEcCtD
Pramipexole—Pruritus—Ramipril—hypertension	4.26e-06	3.62e-05	CcSEcCtD
Pramipexole—Asthenia—Timolol—hypertension	4.22e-06	3.59e-05	CcSEcCtD
Pramipexole—Nausea—Losartan—hypertension	4.17e-06	3.55e-05	CcSEcCtD
Pramipexole—Pruritus—Timolol—hypertension	4.17e-06	3.54e-05	CcSEcCtD
Pramipexole—Diarrhoea—Ramipril—hypertension	4.12e-06	3.5e-05	CcSEcCtD
Pramipexole—Diarrhoea—Timolol—hypertension	4.03e-06	3.42e-05	CcSEcCtD
Pramipexole—Hypersensitivity—Lisinopril—hypertension	4.02e-06	3.42e-05	CcSEcCtD
Pramipexole—Dizziness—Ramipril—hypertension	3.98e-06	3.38e-05	CcSEcCtD
Pramipexole—Asthenia—Lisinopril—hypertension	3.92e-06	3.33e-05	CcSEcCtD
Pramipexole—Dizziness—Timolol—hypertension	3.89e-06	3.31e-05	CcSEcCtD
Pramipexole—Pruritus—Lisinopril—hypertension	3.86e-06	3.28e-05	CcSEcCtD
Pramipexole—Vomiting—Ramipril—hypertension	3.83e-06	3.25e-05	CcSEcCtD
Pramipexole—Rash—Ramipril—hypertension	3.8e-06	3.23e-05	CcSEcCtD
Pramipexole—Dermatitis—Ramipril—hypertension	3.79e-06	3.22e-05	CcSEcCtD
Pramipexole—Headache—Ramipril—hypertension	3.77e-06	3.21e-05	CcSEcCtD
Pramipexole—Vomiting—Timolol—hypertension	3.74e-06	3.18e-05	CcSEcCtD
Pramipexole—Diarrhoea—Lisinopril—hypertension	3.74e-06	3.18e-05	CcSEcCtD
Pramipexole—Rash—Timolol—hypertension	3.71e-06	3.15e-05	CcSEcCtD
Pramipexole—Dermatitis—Timolol—hypertension	3.71e-06	3.15e-05	CcSEcCtD
Pramipexole—Headache—Timolol—hypertension	3.69e-06	3.13e-05	CcSEcCtD
Pramipexole—Dizziness—Lisinopril—hypertension	3.61e-06	3.07e-05	CcSEcCtD
Pramipexole—Nausea—Ramipril—hypertension	3.58e-06	3.04e-05	CcSEcCtD
Pramipexole—Nausea—Timolol—hypertension	3.5e-06	2.97e-05	CcSEcCtD
Pramipexole—Vomiting—Lisinopril—hypertension	3.47e-06	2.95e-05	CcSEcCtD
Pramipexole—Rash—Lisinopril—hypertension	3.44e-06	2.93e-05	CcSEcCtD
Pramipexole—Dermatitis—Lisinopril—hypertension	3.44e-06	2.92e-05	CcSEcCtD
Pramipexole—Headache—Lisinopril—hypertension	3.42e-06	2.91e-05	CcSEcCtD
Pramipexole—Nausea—Lisinopril—hypertension	3.24e-06	2.76e-05	CcSEcCtD
Pramipexole—ADRA2A—Metabolism—ALB—hypertension	5.6e-07	7.85e-06	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—EP300—hypertension	5.6e-07	7.85e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—FGF2—hypertension	5.59e-07	7.84e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL6—hypertension	5.59e-07	7.84e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—RHOA—hypertension	5.57e-07	7.81e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—RELA—hypertension	5.56e-07	7.79e-06	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—SRC—hypertension	5.53e-07	7.76e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCL2—hypertension	5.52e-07	7.74e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IGF1—hypertension	5.52e-07	7.74e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NOTCH1—hypertension	5.52e-07	7.73e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL6—hypertension	5.52e-07	7.73e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AKT2—hypertension	5.52e-07	7.73e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—PIK3R1—hypertension	5.52e-07	7.73e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NOS3—hypertension	5.52e-07	7.73e-06	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—VEGFA—hypertension	5.51e-07	7.72e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—EGFR—hypertension	5.49e-07	7.7e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MAPK8—hypertension	5.48e-07	7.69e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—AKT1—hypertension	5.47e-07	7.67e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MTOR—hypertension	5.45e-07	7.64e-06	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—SRC—hypertension	5.45e-07	7.63e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IGF1—hypertension	5.43e-07	7.61e-06	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TP53—hypertension	5.43e-07	7.61e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AKT2—hypertension	5.43e-07	7.61e-06	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PTEN—hypertension	5.41e-07	7.58e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—EGFR—hypertension	5.4e-07	7.57e-06	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—VEGFA—hypertension	5.39e-07	7.55e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—RELA—hypertension	5.37e-07	7.52e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PIK3R1—hypertension	5.36e-07	7.51e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—NOS3—hypertension	5.36e-07	7.51e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—EP300—hypertension	5.35e-07	7.49e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—RELA—hypertension	5.34e-07	7.48e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MMP9—hypertension	5.32e-07	7.45e-06	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—VEGFA—hypertension	5.3e-07	7.43e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CDKN1A—hypertension	5.3e-07	7.43e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—PTEN—hypertension	5.29e-07	7.41e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MTOR—hypertension	5.26e-07	7.37e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PTEN—hypertension	5.26e-07	7.37e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MMP9—hypertension	5.25e-07	7.35e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SERPINE1—hypertension	5.24e-07	7.35e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CXCL8—hypertension	5.24e-07	7.34e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MTOR—hypertension	5.23e-07	7.34e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CDKN1A—hypertension	5.23e-07	7.33e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—PTEN—hypertension	5.22e-07	7.31e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—SRC—hypertension	5.2e-07	7.29e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—RELA—hypertension	5.19e-07	7.28e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MAPK8—hypertension	5.17e-07	7.25e-06	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—EP300—hypertension	5.16e-07	7.23e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—AKT1—hypertension	5.16e-07	7.23e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SERPINE1—hypertension	5.16e-07	7.23e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—POMC—hypertension	5.14e-07	7.2e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—INS—hypertension	5.11e-07	7.16e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MAPK8—hypertension	5.1e-07	7.15e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MTOR—hypertension	5.09e-07	7.14e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—AKT1—hypertension	5.09e-07	7.13e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—FGF2—hypertension	5.07e-07	7.11e-06	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MYC—hypertension	5.07e-07	7.1e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—VEGFA—hypertension	5.06e-07	7.1e-06	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—AKT1—hypertension	5.06e-07	7.09e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—RHOA—hypertension	5.06e-07	7.09e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CXCL8—hypertension	5.06e-07	7.09e-06	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TGFB1—hypertension	5.05e-07	7.08e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—EP300—hypertension	5.04e-07	7.07e-06	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PTEN—hypertension	5.04e-07	7.07e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CXCL8—hypertension	5.03e-07	7.05e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCL2—hypertension	5.03e-07	7.04e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—EP300—hypertension	5.02e-07	7.03e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PIK3R1—hypertension	5e-07	7.01e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NOS3—hypertension	5e-07	7.01e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—FGF2—hypertension	4.99e-07	7e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL6—hypertension	4.98e-07	6.98e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RHOA—hypertension	4.98e-07	6.97e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—EP300—hypertension	4.97e-07	6.97e-06	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL6—hypertension	4.97e-07	6.97e-06	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MYC—hypertension	4.96e-07	6.95e-06	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—EGFR—hypertension	4.95e-07	6.94e-06	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TGFB1—hypertension	4.95e-07	6.93e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IGF1—hypertension	4.94e-07	6.93e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AKT2—hypertension	4.94e-07	6.92e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PIK3R1—hypertension	4.92e-07	6.9e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NOS3—hypertension	4.92e-07	6.9e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—EGFR—hypertension	4.92e-07	6.89e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—SRC—hypertension	4.9e-07	6.87e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PTGS2—hypertension	4.9e-07	6.87e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CXCL8—hypertension	4.89e-07	6.86e-06	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—AKT1—hypertension	4.88e-07	6.85e-06	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MYC—hypertension	4.88e-07	6.84e-06	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TGFB1—hypertension	4.87e-07	6.82e-06	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—AKT1—hypertension	4.86e-07	6.81e-06	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—EGFR—hypertension	4.85e-07	6.8e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—SRC—hypertension	4.84e-07	6.78e-06	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—EP300—hypertension	4.81e-07	6.74e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL6—hypertension	4.81e-07	6.74e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL6—hypertension	4.78e-07	6.7e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—VEGFA—hypertension	4.78e-07	6.69e-06	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—EGFR—hypertension	4.77e-07	6.69e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MMP9—hypertension	4.74e-07	6.64e-06	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—AKT1—hypertension	4.73e-07	6.62e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CDKN1A—hypertension	4.72e-07	6.62e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—VEGFA—hypertension	4.71e-07	6.6e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—RELA—hypertension	4.71e-07	6.6e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—PTEN—hypertension	4.71e-07	6.6e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SERPINE1—hypertension	4.69e-07	6.58e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MYC—hypertension	4.66e-07	6.53e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL6—hypertension	4.65e-07	6.52e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TGFB1—hypertension	4.65e-07	6.51e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RELA—hypertension	4.63e-07	6.5e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MTOR—hypertension	4.62e-07	6.47e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MAPK8—hypertension	4.61e-07	6.46e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—AKT1—hypertension	4.59e-07	6.44e-06	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—AKT1—hypertension	4.59e-07	6.43e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MMP9—hypertension	4.57e-07	6.41e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—EGFR—hypertension	4.56e-07	6.39e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CDKN1A—hypertension	4.56e-07	6.39e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MMP9—hypertension	4.55e-07	6.38e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—PTEN—hypertension	4.55e-07	6.37e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MTOR—hypertension	4.55e-07	6.37e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—FGF2—hypertension	4.54e-07	6.37e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CDKN1A—hypertension	4.53e-07	6.35e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RHOA—hypertension	4.53e-07	6.34e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—PTEN—hypertension	4.52e-07	6.34e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—EP300—hypertension	4.49e-07	6.29e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PIK3R1—hypertension	4.48e-07	6.28e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NOS3—hypertension	4.48e-07	6.28e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MAPK8—hypertension	4.45e-07	6.23e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CXCL8—hypertension	4.44e-07	6.22e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—AKT1—hypertension	4.44e-07	6.22e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MMP9—hypertension	4.43e-07	6.2e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MAPK8—hypertension	4.42e-07	6.2e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—AKT1—hypertension	4.41e-07	6.18e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CDKN1A—hypertension	4.41e-07	6.18e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—PTEN—hypertension	4.4e-07	6.17e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MYC—hypertension	4.39e-07	6.16e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TGFB1—hypertension	4.38e-07	6.14e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CXCL8—hypertension	4.37e-07	6.12e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—SRC—hypertension	4.37e-07	6.12e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—EP300—hypertension	4.34e-07	6.08e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MYC—hypertension	4.34e-07	6.08e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TGFB1—hypertension	4.32e-07	6.06e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—EP300—hypertension	4.31e-07	6.05e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MAPK8—hypertension	4.3e-07	6.03e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—EGFR—hypertension	4.3e-07	6.02e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—AKT1—hypertension	4.29e-07	6.02e-06	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—AKT1—hypertension	4.29e-07	6.01e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PTEN—hypertension	4.27e-07	5.99e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—VEGFA—hypertension	4.25e-07	5.96e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—EGFR—hypertension	4.24e-07	5.94e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL6—hypertension	4.22e-07	5.92e-06	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—AKT1—hypertension	4.22e-07	5.91e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RELA—hypertension	4.22e-07	5.91e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SRC—hypertension	4.22e-07	5.91e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—EP300—hypertension	4.2e-07	5.88e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SRC—hypertension	4.19e-07	5.88e-06	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TP53—hypertension	4.16e-07	5.83e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL6—hypertension	4.15e-07	5.82e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MTOR—hypertension	4.14e-07	5.8e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—VEGFA—hypertension	4.11e-07	5.76e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—VEGFA—hypertension	4.09e-07	5.73e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SRC—hypertension	4.08e-07	5.72e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—EP300—hypertension	4.08e-07	5.71e-06	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TP53—hypertension	4.07e-07	5.71e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MMP9—hypertension	4.02e-07	5.63e-06	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TP53—hypertension	4.01e-07	5.62e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CDKN1A—hypertension	4e-07	5.61e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PTEN—hypertension	3.99e-07	5.59e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CXCL8—hypertension	3.97e-07	5.57e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—VEGFA—hypertension	3.97e-07	5.57e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MMP9—hypertension	3.95e-07	5.54e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CDKN1A—hypertension	3.94e-07	5.52e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PTEN—hypertension	3.93e-07	5.5e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MYC—hypertension	3.91e-07	5.49e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MAPK8—hypertension	3.9e-07	5.47e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TGFB1—hypertension	3.9e-07	5.47e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—AKT1—hypertension	3.89e-07	5.46e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MAPK8—hypertension	3.84e-07	5.38e-06	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—AKT1—hypertension	3.84e-07	5.38e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—AKT1—hypertension	3.83e-07	5.37e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—EGFR—hypertension	3.83e-07	5.37e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TP53—hypertension	3.83e-07	5.36e-06	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL6—hypertension	3.81e-07	5.34e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—EP300—hypertension	3.81e-07	5.34e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL6—hypertension	3.78e-07	5.3e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MYC—hypertension	3.78e-07	5.3e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TGFB1—hypertension	3.77e-07	5.28e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MYC—hypertension	3.76e-07	5.27e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TGFB1—hypertension	3.75e-07	5.26e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—EP300—hypertension	3.75e-07	5.25e-06	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL6—hypertension	3.73e-07	5.23e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SRC—hypertension	3.7e-07	5.19e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—EGFR—hypertension	3.7e-07	5.18e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—EGFR—hypertension	3.68e-07	5.15e-06	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL6—hypertension	3.67e-07	5.14e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MYC—hypertension	3.66e-07	5.12e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TGFB1—hypertension	3.65e-07	5.11e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SRC—hypertension	3.64e-07	5.1e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TP53—hypertension	3.61e-07	5.06e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—VEGFA—hypertension	3.61e-07	5.05e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MMP9—hypertension	3.59e-07	5.04e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CDKN1A—hypertension	3.58e-07	5.02e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—EGFR—hypertension	3.58e-07	5.01e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PTEN—hypertension	3.57e-07	5.01e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TP53—hypertension	3.56e-07	4.99e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—VEGFA—hypertension	3.55e-07	4.97e-06	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—AKT1—hypertension	3.51e-07	4.92e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL6—hypertension	3.5e-07	4.91e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MAPK8—hypertension	3.5e-07	4.9e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—AKT1—hypertension	3.49e-07	4.89e-06	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—AKT1—hypertension	3.44e-07	4.82e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—EP300—hypertension	3.41e-07	4.78e-06	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—AKT1—hypertension	3.38e-07	4.74e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MYC—hypertension	3.32e-07	4.65e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SRC—hypertension	3.31e-07	4.64e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TGFB1—hypertension	3.31e-07	4.64e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL6—hypertension	3.3e-07	4.63e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MYC—hypertension	3.26e-07	4.57e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL6—hypertension	3.26e-07	4.57e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TGFB1—hypertension	3.26e-07	4.56e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—EGFR—hypertension	3.24e-07	4.55e-06	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AKT1—hypertension	3.23e-07	4.53e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—VEGFA—hypertension	3.23e-07	4.52e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TP53—hypertension	3.21e-07	4.5e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—EGFR—hypertension	3.19e-07	4.47e-06	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—AKT1—hypertension	3.12e-07	4.37e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TP53—hypertension	3.1e-07	4.35e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TP53—hypertension	3.09e-07	4.33e-06	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AKT1—hypertension	3.05e-07	4.27e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—AKT1—hypertension	3.03e-07	4.25e-06	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AKT1—hypertension	3.01e-07	4.21e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TP53—hypertension	3e-07	4.21e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MYC—hypertension	2.97e-07	4.16e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TGFB1—hypertension	2.96e-07	4.15e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6—hypertension	2.94e-07	4.12e-06	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—AKT1—hypertension	2.91e-07	4.07e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—EGFR—hypertension	2.9e-07	4.07e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6—hypertension	2.84e-07	3.98e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6—hypertension	2.83e-07	3.96e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL6—hypertension	2.75e-07	3.85e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TP53—hypertension	2.72e-07	3.82e-06	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AKT1—hypertension	2.71e-07	3.8e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TP53—hypertension	2.68e-07	3.76e-06	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AKT1—hypertension	2.62e-07	3.67e-06	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AKT1—hypertension	2.61e-07	3.65e-06	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AKT1—hypertension	2.54e-07	3.55e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL6—hypertension	2.49e-07	3.49e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—AKT1—hypertension	2.46e-07	3.45e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6—hypertension	2.45e-07	3.44e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TP53—hypertension	2.44e-07	3.42e-06	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AKT1—hypertension	2.3e-07	3.22e-06	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AKT1—hypertension	2.26e-07	3.17e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL6—hypertension	2.23e-07	3.13e-06	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AKT1—hypertension	2.06e-07	2.89e-06	CbGpPWpGaD
